Sicagen India Ltd

Sicagen India Annual General Meeting

Sicagen India Ltd held its 22nd Annual General Meeting on September 17, 2026. The meeting transacted ordinary and special business as per the agenda.

Sicagen India Other Announcement

Sicagen India has issued a notice to physical shareholders requesting mandatory updation of PAN, KYC, and nomination details with the company's RTA, in line with SEBI circulars.

Sicagen India Annual General Meeting

Sicagen India Limited issued a notice for its 22nd Annual General Meeting to be held on September 17, 2026, via video conferencing.

Sicagen India Annual General Meeting

Sicagen India Ltd has scheduled its 22nd Annual General Meeting for September 17, 2026. The meeting will be held via video conferencing to transact ordinary and special business.

Value

₹0.01 Cr

Sicagen India Annual Report

Sicagen India Ltd has submitted its 22nd Annual Report for the financial year 2025-26. The report includes audited financial statements, directors' report, and corporate governance details.

Sicagen India Annual General Meeting

Sicagen India Ltd approved its quarterly financial results and scheduled the 22nd Annual General Meeting for September 17, 2026. A record date for dividend was also fixed.

Sicagen India Q1 FY27 Results: Net Profit ₹6.9 Cr, Up 53.3% YoY

Sicagen India Ltd reported revenue from operations of ₹286 Cr (+39.9% YoY) and net profit of ₹6.9 Cr (+53.3% YoY) for Q1 FY27.

Key figure

Net profit ₹6.9 Cr · +53.3% YoY

Sicagen India Board Meeting Date

Sicagen India Ltd scheduled a board meeting for August 10, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2026.

Sicagen India Other Announcement

Sicagen India Ltd filed its quarterly shareholding pattern. The document details the distribution of equity shares among promoters and public shareholders.

Sicagen India Annual General Meeting

Sicagen India announced the results of its Postal Ballot. Shareholders approved the appointment of Mr. Prasanna Joshi as a Director and Whole-Time Director with requisite majority.